The results were consistent with our findings, indicating that CASP1, CYSLTR1, DPYD, FLT3, NOTCH2, PAK1, PIK3R5, and SLC44A1 were significantly upregulated in AML in comparison to the control (Figure S2). Here, PAK1 is linked to acute myeloid leukemia.